A strategic alliance: PharmEng Technology joins the Efor group

We are proud to announce the acquisition of PharmEng Technology, a renowned Canadian company recognized for its expertise in validation, quality assurance, regulatory affairs, and engineering. This major milestone marks a turning point in our ambition to become a global leader in life sciences consulting by 2028.

A Global Group Ready for Complex Challenges

Through this partnership, we now form a global group of 2,800 employees across 12 countries, prepared to tackle the complex challenges of the pharmaceutical, biotechnology, and medical device industries.

Strengthened Global Presence

This acquisition significantly extends our geographical footprint by adding eight new markets: Canada, Brazil, Ireland, Denmark, Spain, Singapore, Malaysia, and Indonesia, while also strengthening our operations in the United States. This global reach uniquely positions us to support our clients’ international projects while addressing the local specifics of various regions.

Complementary Strengths to Address Industry Challenges

With over 25 years of expertise, PharmEng Technology brings invaluable added value to our offerings, enriching them with solutions that span the entire lifecycle of healthcare products—from research and development to market launch, regulatory compliance, and vigilance. Together, we enhance our ability to provide comprehensive, integrated solutions tailored to the evolving demands of the industry.

A Shared Vision of Excellence

“This union is a key step in our mission to transform the life sciences sector. We are confident that this strategic alliance will strengthen our ability to innovate, perform, and deliver excellence to our clients.” – Mathieu Roger, Founder and President of Efor

“This partnership is built on shared values and a common ambition. Together, we will combine our strengths to better support industrial players across three continents.” – Alan Kwong, Founder and President of PharmEng Technology

With this acquisition, we affirm our role as a trusted partner for the life sciences industry, capable of anticipating trends, driving innovation, and delivering solutions that meet the demands of a rapidly evolving sector.